Good Post Marketing Study Practice
Showing 1 - 25 of >10,000
Data of Intravitreal Aflibercept Injection in Patients of Wet
Completed
- Wet Age-related Macular Degeneration
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, IndiaMany Locations
Feb 2, 2023
(Use-results Surveillance) With Esperoct®
Enrolling by invitation
- Haemophilia A
- Turoctocog alfa pegol
-
Fukuoka, Japan
- +14 more
Nov 8, 2022
(Special Use-results Surveillance on Long-term Use) With
Enrolling by invitation
- Adult Growth Hormone Deficiency
-
Fukuoka, Japan
- +6 more
Nov 8, 2022
Elonva (Corifollitropin Alfa) in General Practice (P08165)
Completed
- Infertility, Female
- corifollitropin alfa
- (no location specified)
Feb 1, 2022
ELIQUIS Regulatory Post-Marketing Surveillance In Clinical
Completed
- Venous Thromboembolism
-
Shinjuku-ku, Tokyo, JapanLocal Institution
Feb 3, 2022
Assess Speed of Onset and Durability of Effectiveness of
Not yet recruiting
- Crohn's Disease
- (no location specified)
Jun 27, 2023
Hemophilia B Trial in Pune (RIXUBIS: On-Demand, RIXUBIS: Prophylaxis)
Completed
- Hemophilia B
- RIXUBIS: On-Demand
- RIXUBIS: Prophylaxis
-
Pune, Maharashtra, IndiaSahyadri Super Speciality Hospital
Aug 4, 2022
(rPMS) Study of Xultophy® to Evaluate Safety and Effectiveness
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Xultophy® (insulin degludec/liraglutide)
-
Daejeon, Cheongsa-ro, Seo-gu, Korea, Republic of
- +9 more
Mar 21, 2022
Sogroya® in Short Stature Due to Growth Hormone Deficiency Where
Recruiting
- Growth Hormone Deficiency in Children
-
Tokyo, JapanNovo Nordisk Investigational Site
Oct 25, 2023
Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)
Recruiting
- SARS-CoV-2 Infection
-
Aichi, Japan
- +2 more
Jan 17, 2023
Venetoclax Treatment in Chronic Lymphocytic Leukemia Routine
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
-
Be'er Sheva, HaDarom, Israel
- +12 more
Sep 9, 2022
Prostatic Tumors, Castration-Resistant Trial in Multiple Locations (Radium-223 dichloride (Xofigo, BAY 88-8223))
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- Radium-223 dichloride (Xofigo, BAY 88-8223)
-
Multiple Locations, Japan(unnamed)
Feb 2, 2023
Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -
Not yet recruiting
- Biliary Tract Cancer
- (no location specified)
Apr 26, 2023
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance
Not yet recruiting
- Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
- (no location specified)
Dec 16, 2022
Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing
Not yet recruiting
- Unresectable Hepatocellular Carcinoma
- (no location specified)
Dec 19, 2022
BIOFLOW-china Post-marketing Study (BIOTRONIK)
Not yet recruiting
- In-Stent Stenosis (Restenosis) of Coronary Artery Stent
- Native Coronary Artery Stenosis
- BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
-
Harbin, Heilongjiang, ChinaThe Fourth Affiliated Hospital of Harbin Medical University
Dec 26, 2022
Hemophilia A Trial in India (ADVATE)
Recruiting
- Hemophilia A
- ADVATE
-
Ernakulam, Kerala, India
- +4 more
Jan 17, 2022
(rPMS) Study of Ryzodeg® FlexTouch® to Evaluate Safety and
Completed
- Diabetes
- +2 more
- Insulin degludec /insulin aspart
-
Busan, Korea, Republic of
- +26 more
Nov 9, 2021
Evaluation of POMALYST® Treatment of Multiple Myeloma in Korea
Recruiting
- Multiple Myeloma
- POMALYST® (Pomalidomide)
-
Ansan, Korea, Republic of
- +32 more
Aug 17, 2022
PASS of Paediatric Patients Initiating Selumetinib
Recruiting
- Neurofibromatosis Type 1
-
Angers, France
- +3 more
Jan 12, 2023
Venetoclax for Chronic Lymphocytic Leukemia Used in Routine
Recruiting
- Cancer, Chronic Lymphocytic Leukemia (CLL)
-
Seoul, Seoul Teugbyeolsi, Korea, Republic of
- +7 more
Mar 17, 2022